Acetyldigitoxin
Acetyldigitoxin may decrease the cardiotoxic activities of Decitabine.
Ancestim
The risk or severity of cytotoxicity can be increased when Ancestim is combined with Decitabine.
Bevacizumab
Bevacizumab may increase the cardiotoxic activities of Decitabine.
Advertisement
Bevacizumab-Awwb
Bevacizumab may increase the cardiotoxic activities of Decitabine.
Cabazitaxel
The risk or severity of adverse effects can be increased when Cabazitaxel is combined with Decitabine.
Clozapine
The risk or severity of adverse effects can be increased when Decitabine is combined with Clozapine.
Advertisement
Cyclophosphamide
Cyclophosphamide may increase the cardiotoxic activities of Decitabine.
Cyclophosphamide Anhydrous
Cyclophosphamide may increase the cardiotoxic activities of Decitabine.
Deslanoside
Deslanoside may decrease the cardiotoxic activities of Decitabine.
Advertisement
Digitoxin
Digitoxin may decrease the cardiotoxic activities of Decitabine.
Digoxin
Digoxin may decrease the cardiotoxic activities of Decitabine.
Dipyrone
The risk or severity of myelosuppression can be increased when Metamizole is combined with Decitabine.
Docetaxel
The risk or severity of adverse effects can be increased when Docetaxel is combined with Decitabine.
DOCETAXEL ANHYDROUS
The risk or severity of adverse effects can be increased when Docetaxel is combined with Decitabine.
Lipegfilgrastim
Decitabine may increase the myelosuppressive activities of Lipegfilgrastim.
Ouabain
Ouabain may decrease the cardiotoxic activities of Decitabine.
Ovine Digoxin Immune Fab
Digoxin Immune Fab (Ovine) may decrease the cardiotoxic activities of Decitabine.
Paclitaxel
The risk or severity of adverse effects can be increased when Paclitaxel is combined with Decitabine.
Proscillaridin
Proscillaridin may decrease the cardiotoxic activities of Decitabine.
Trastuzumab
Trastuzumab may increase the cardiotoxic activities of Decitabine.
